Novel three-dimensional in vitro models of ovarian endometriosis

Journal of Ovarian Research

Volumn 7, Issue 1, 2014, Pages

  Brueggmann, Doerthe ^a   Templeman, Claire ^a   Starzinski Powitz, Anna ^b   Rao, Nagesh P ^c   Gayther, Simon A ^a   Lawrenson, Kate ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell culture; Endometriosis; Ovary; Real time semi quantitative PCR; RNA sequencing; Three dimensional in vitro modeling

Indexed keywords

RNA; BIOLOGICAL MARKER;

ADULT; ARTICLE; CASE REPORT; CELL ASSAY; CELL STRUCTURE; CONTROLLED STUDY; DISEASE MODEL; ENDOMETRIOSIS; ENDOMETRIOSIS EPITHELIAL CELL; ENDOMETRIUM CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MONOLAYER CULTURE; OVARY CELL CULTURE; OVARY DISEASE; OVARY ENDOMETRIOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; WESTERN BLOTTING; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TIME;

ADULT; BIOLOGICAL MARKERS; CELL LINE; CELL PROLIFERATION; ENDOMETRIOSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; OVARIAN DISEASES; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SPHEROIDS, CELLULAR; TIME FACTORS;

EID: 84899070616     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-7-17     Document Type: Article

References (30)

1. Epidemiology of endometriosis. Eskenazi B, Warner ML, Obstet Gynecol Clin North Am 1997 24 2 235 258 10.1016/S0889-8545(05)70302-8 9163765
2. Endometriosis. Bulun SE, N Engl J Med 2009 360 3 268 279 10.1056/NEJMra0804690 19144942
3. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, et al. Lancet Oncol 2012 13 4 385 394 10.1016/S1470-2045(11)70404-1 22361336
4. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Nisolle M, Donnez J, Fertil Steril 1997 68 4 585 596 10.1016/S0015-0282(97)00191-X 9341595
5. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Sainz de la Cuesta R, Eichhorn JH, Rice LW, Fuller AF, Nikrui N, Goff BA, Gynecol Oncol 1996 60 2 238 244 10.1006/gyno.1996.0032 8631545
6. Frequency of ovarian endometriosis in epithelial ovarian cancer patients. Dzatic-Smiljkovic O, Vasiljevic M, Djukic M, Vugdelic R, Vugdelic J, Clin Exp Obstet Gynecol 2011 38 4 394 398 22268283
7. Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells. Banu SK, Lee J, Starzinski-Powitz A, Arosh JA, Fertil Steril 2008 90 4 972 987 10.1016/j.fertnstert.2007.07.1358 18001719
8. Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans. Banu SK, Starzinski-Powitz A, Speights VO, Burghardt RC, Arosh JA, Fertil Steril 2009 91 5 Suppl 2199 2209 18722604
9. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Wu Y, Starzinski-Powitz A, Guo SW, Reprod Sci 2007 14 4 374 382 10.1177/ 1933719107302913 17644810
10. The role of DJ-1 in the pathogenesis of endometriosis. Rai P, Shivaji S, PLoS One 2011 6 3 18074 10.1371/journal.pone.0018074 21445310
11. Junction protein shrew-1 influences cell invasion and interacts with invasion-promoting protein CD147. Schreiner A, Ruonala M, Jakob V, Suthaus J, Boles E, Wouters F, Starzinski-Powitz A, Mol Biol Cell 2007 18 4 1272 1281 10.1091/mbc.E06-07-0637 17267690
12. Putting tumours in context. Bissell MJ, Radisky D, Nat Rev Cancer 2001 1 1 46 54 10.1038/35094059 11900251
13. Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. Grun B, Benjamin E, Sinclair J, Timms JF, Jacobs IJ, Gayther SA, Dafou D, Cell Prolif 2009 42 2 219 228 10.1111/j.1365-2184.2008.00579.x 19222485
14. In vitro three-dimensional modelling of human ovarian surface epithelial cells. Lawrenson K, Benjamin E, Turmaine M, Jacobs I, Gayther S, Dafou D, Cell Prolif 2009 42 3 385 393 10.1111/j.1365-2184.2009.00604.x 19397591
15. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lee JM, Mhawech-Fauceglia P, Lee N, Parsanian LC, Lin YG, Gayther SA, Lawrenson K, Lab Invest 2013 93 5 528 542 10.1038/labinvest.2013.41 23459371
16. A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro. Li NF, Wilbanks G, Balkwill F, Jacobs IJ, Dafou D, Gayther SA, Lab Invest 2004 84 7 923 931 10.1038/labinvest.3700093 15077121
17. Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model. Zeitvogel A, Baumann R, Starzinski-Powitz A, Am J Pathol 2001 159 5 1839 1852 10.1016/S0002-9440(10) 63030-1 11696444
18. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW, Cancer Cell 2006 10 6 515 527 10.1016/j.ccr.2006.10.008 17157791
19. Epithelial cells in peritoneal fluid-of endometrial origin? van der Linden PJ, Dunselman GA, de Goeij AF, van der Linden EP, Evers JL, Ramaekers FC, Am J Obstet Gynecol 1995 173 2 566 570 10.1016/0002-9378(95)90283-X 7544070
20. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A, Am J Pathol 1997 150 2 461 467 9033262
21. Creation of immortalised epithelial cells from ovarian endometrioma. Bono Y, Kyo S, Takakura M, Maida Y, Mizumoto Y, Nakamura M, Nomura K, Kiyono T, Inoue M, Br J Cancer 2012 106 6 1205 1213 10.1038/bjc.2012.26 22353808
22. Parental-origin-specific epigenetic modification of the mouse H19 gene. Ferguson-Smith AC, Sasaki H, Cattanach BM, Surani MA, Nature 1993 362 6422 751 755 10.1038/362751a0 8469285
23. Tumour-suppressor activity of H19 RNA. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B, Nature 1993 365 6448 764 767 10.1038/365764a0 7692308
24. An Italian association study and meta-analysis with previous GWAS confirm WNT4, CDKN2BAS and FN1 as the first identified susceptibility loci for endometriosis. Pagliardini L, Gentilini D, Vigano P, Panina-Bordignon P, Busacca M, Candiani M, Di Blasio AM, J Med Genet 2013 50 1 43 46 10.1136/jmedgenet- 2012-101257 23142796
25. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nyholt DR, Low SK, Anderson CA, Painter JN, Uno S, Morris AP, MacGregor S, Gordon SD, Henders AK, Martin NG, Attia J, Holliday EG, McEvoy M, Scott RJ, Kennedy SM, Treloar SA, Missmer SA, Adachi S, Tanaka K, Nakamura Y, Zondervan KT, Zembutsu H, Montgomery GW, Nat Genet 2012 44 12 1355 1359 10.1038/ng.2445 23104006
26. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. Wiegand KC, Lee AF, Al-Agha OM, Chow C, Kalloger SE, Scott DW, Steidl C, Wiseman SM, Gascoyne RD, Gilks B, Huntsman DG, J Pathol 2011 224 3 328 333 10.1002/path.2911 21590771
27. Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers. Lowery WJ, Schildkraut JM, Akushevich L, Bentley R, Marks JR, Huntsman D, Berchuck A, Int J Gynecol Cancer 2012 22 1 9 14 10.1097/IGC.0b013e318231f140 22193641
28. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Tsuchiya A, Sakamoto M, Yasuda J, Chuma M, Ohta T, Ohki M, Yasugi T, Taketani Y, Hirohashi S, Am J Pathol 2003 163 6 2503 2512 10.1016/S0002-9440(10)63605-X 14633622
29. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Obata K, Morland SJ, Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, Campbell IG, Cancer Res 1998 58 10 2095 2097 9605750
30. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. Dit Faute MA, Laurent L, Ploton D, Poupon MF, Jardillier JC, Bobichon H, Clin Exp Metastasis 2002 19 2 161 168 10.1023/A:1014594825502 11964080